返回
RemeGen Co., Ltd.（09995.HK）價格
09995.HK 股價走勢圖
REMEGEN (09995.HK)
RemeGen Co., Ltd.
HK$93.95
-1.41%
$-1.34
休市： Jan 20, 16:00:00 HKT
關鍵數據
前收市價
$95.2
開盤價
$95.3
當日範圍
$92 - $95.8
52週區間
$11.52 - $126.6
交易量
4.6M
平均成交量
5.2M
每股盈餘 (TTM)
-2.35
股息收益率
--
市值
$19.5B
什麼是 REMEGEN？
RemeGen Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Yantai, Shandong and currently employs 2,999 full-time employees. The company went IPO on 2020-11-09. RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The firm focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The firm's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The firm mainly operates its businesses in the domestic and overseas markets.